“…These carcinomas also show ductal and papillary configurations and should be differentiated from acinic cell carcinoma, mucoepidermoid carcinoma, papillary cystadenocarcinoma, polymorphous low-grade adenocarcinoma, epithelial-myoepithelial carcinoma and oncocytic carcinoma [1,4,55,70,71,73]. The tumor has been found to be immunoreactive for cytokeratins, variably reactive EMA and unreactive for S-100 protein and myosin [107].…”